论文部分内容阅读
目的分析并评价我院2010-2012年颅内恶性肿瘤患者的用药情况。方法利用统计软件对我院神经外科2010-2012年的恶性肿瘤患者的用药种类、用药总量、销售价格等进行统计,并计算各种药物的DDC、DDDs以及B/A。结果颅内恶性肿瘤患者的用药种类广,几乎各类药均有使用,其中主要使用的药物包括抗感染药物(35.27%)、神经系统药物(16.48%)、心血管系统药物(11.83%)。结论颅内恶性肿瘤患者需要多种药物协同应用,其中抗感染药物占首位。我院对颅内恶性肿瘤患者的用药情况基本合理,在治疗中根据患者的个体差异,随时调整药物的种类和剂量,具体问题具体分析。
Objective To analyze and evaluate the treatment of intracranial malignant tumors in our hospital from 2010 to 2012. Methods Statistical software was used to calculate the types of drugs, the total amount of drugs used, the sales prices of malignant tumor patients in our hospital from 2010 to 2012 and calculate the DDC, DDDs and B / A of various drugs. Results The patients with intracranial malignant tumors had a wide range of drugs and almost all kinds of drugs were used. The main drugs used included anti-infective drugs (35.27%), neurological drugs (16.48%) and cardiovascular drugs (11.83%). Conclusions Patients with intracranial malignant tumor need a variety of drugs synergistically, including anti-infective drugs in the first place. Our hospital on the intracranial malignant tumor patients medication basically reasonable, according to the patient’s individual differences in treatment, the type and dose of medication at any time to adjust the specific problems of specific analysis.